Zydus Cadila

Zydus Cadila News

COVID-19 variant Omicron spreads to more countries as world on alert
World

COVID-19 variant Omicron spreads to more countries as world on alert

New cases were confirmed Saturday in Germany and Italy, with Belgium, Israel and Hong Kong also reporting that the variant has been found in travellers

Zydus Cadila's COVID vaccine to be administered only to adults as of now, say sources
India

Zydus Cadila's COVID vaccine to be administered only to adults as of now, say sources

The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on 20 August

Zydus Cadila may reduce its Covid vaccine price to Rs 265 a dose, final decision soon
India

Zydus Cadila may reduce its Covid vaccine price to Rs 265 a dose, final decision soon

The Ahmedabad-based pharma company earlier had proposed a price of Rs 1,900 for its three-dose regimen, sources said.

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success
India

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success

Representatives from seven vaccine makers — Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech — participated in the meeting

Centre will decide on vaccination of children, adolescents on ‘scientific rationale’, says COVID Task Force chief
India

Centre will decide on vaccination of children, adolescents on ‘scientific rationale’, says COVID Task Force chief

Zydus Cadila’s needle-free vaccine ZyCoV-D is set to become the first vaccine that will be available in India for those in the age group of 12-18 years

Covaxin recommended by expert panel for kids: All you need to know about children's COVID-19 shot
India

Covaxin recommended by expert panel for kids: All you need to know about children's COVID-19 shot

Children will be given half the proportion of what adults get ie, a dose of 0.5 ml will be given to kids compared to 1ml in adults. It will be an intramuscular injection like other vaccines

Conversation between Zydus Cadila, Centre underway on pricing for first DNA-based needle-free COVID-19 vaccine
India

Conversation between Zydus Cadila, Centre underway on pricing for first DNA-based needle-free COVID-19 vaccine

The pharma company is learnt to have proposed ₹1,900 for its three-dose jab that can be given to those above 12 years of age.

Zydus Cadila proposes Rs 1,900 for three-dose COVID vaccine; Centre negotiating to bring price down
India

Zydus Cadila proposes Rs 1,900 for three-dose COVID vaccine; Centre negotiating to bring price down

The government had said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila will be introduced in the nationwide anti-coronavirus vaccination drive shortly.

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19
India

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19

While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October
India

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October

The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi

Over 70.63 crore COVID-19 vaccine doses provided to states and UTs thus far, says Centre
India

Over 70.63 crore COVID-19 vaccine doses provided to states and UTs thus far, says Centre

The health ministry said more than 5.58 crore balance and unutilised COVID-19 vaccine doses are still available with the states and UTs to be administered

ZyCoV-D to come at
India

ZyCoV-D to come at "affordable price", market launch likely by Sept end, says Zydus group MD

ZyCoV-D was approved by the country’s apex drug regulator, Drug Controller General of India (DCGI), on August 20. The first indigenously-developed vaccine in India is Bharat Biotech’s Covaxin.

Zydus Cadila's COVID-19 vaccine okayed in India: From interval between doses to efficacy, here's what you must know
India

Zydus Cadila's COVID-19 vaccine okayed in India: From interval between doses to efficacy, here's what you must know

The Zydus Cadila vaccine, world's first to use the DNA technology against Sars-Cov-2, is 66 percent effective and expected to hit the market late September or early October

Zydus Cadila vaccine gets EUA for adolescents: A look at scientific, ethical concerns in inoculating minors for COVID-19
India

Zydus Cadila vaccine gets EUA for adolescents: A look at scientific, ethical concerns in inoculating minors for COVID-19

Nations like the US, the UK, France, have already begun vaccinating their adolescent population, while Israel, Chile and Malta have achieved one of the highest COVID-19 vaccination rates in the world

Explained: 'India to have world's first DNA vaccine', here's how the ZyCoV-D shot works
India

Explained: 'India to have world's first DNA vaccine', here's how the ZyCoV-D shot works

These vaccines work by inserting a piece of the virus's genetic information into the body to prompt cells to produce a key component of the virus which the immune system then recognises and attacks by producing antibodies

Zydus Cadila's vaccine may be available for children soon, trials nearly complete, Centre informs Delhi HC
India

Zydus Cadila's vaccine may be available for children soon, trials nearly complete, Centre informs Delhi HC

The court observed that it would be a 'disaster' if COVID-19 vaccines are administered to children without conducting proper research

Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot
India

Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot

Dr Sharvil Patel, managing director, Cadila Healthcare, ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group

India okays Moderna vaccine for emergency use: How does it work and how effective is it?
India

India okays Moderna vaccine for emergency use: How does it work and how effective is it?

Moderna vaccine: The Moderna jab was the second vaccine to get an emergency nod in the US after the Pfizer vaccine, another mRNA shot

India records 50,040 new COVID-19 cases, 1,258 fresh fatalities; active cases less than 2%
India

India records 50,040 new COVID-19 cases, 1,258 fresh fatalities; active cases less than 2%

India administered 64.25 lakh vaccine doses in a day, taking the cumulative number of jabs given so far under the nationwide inoculation drive to 32.17 crore, according to immunisation data published at 7 am

In affidavit filed in SC, Centre lays out plan to vaccinate adult population against COVID-19 by year-end
India

In affidavit filed in SC, Centre lays out plan to vaccinate adult population against COVID-19 by year-end

The Centre said 51.6 crore doses will be made available for administration by 31 July and submitted the projected availability of vaccines for different sources from August to December for 135 crore doses